DDIT3 and liver cancer: In summary, we found that CTLL-2 cells undergo ER stress that causes cell depletion through the PERK-CHOP pathway, and ER stress and restoration of cell functions can be partly reversed by adding TP, which provides a potential new therapeutic approach to treat liver cancer.